AsCNP Science Award
AsCNP commences its science award since 2019. This award includes two winners, namely from clinical and basic research scholars, to recognize their great achievements in the field of neuropsychopharmacology. This prize consists of a monetary award of $1,000 (USD) and an engraved plaque for each winner, to be presented at the biannual congress meeting (Morning, September 22，2023，Xi‘An)
Guidelines
- The nominator and nominee should be the member of AsCNP.
- Nominator’s letter of recommendation includes a 500-word statement which summarizes the nominee’s current work activity and achievement
- Nominee’s curriculum vitae include a list of publications.
- The application will begin from 21th Apr 2023 to 30th May 2023. The results will be announced on 1st July.
- The application should be sent to AsCNP Central Office (secretariatascnp.org).
Please fax or mail this application to：
Asian College of Neuropsychopharmacology (AsCNP)
c/o A & E Planning Co., Ltd.
E-mail : secretariatascnp.org
Fax : +81-3-3230-2479
c/o A & E Planning Co., Ltd.
E-mail : secretariatascnp.org
Fax : +81-3-3230-2479
Awardee
| 2021 Awardee | |
| Tadafumi Kato (Japan) |
The Head of Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan |
|---|---|
| Zhong Chen (China) |
The President of Zhejiang Chinese Medical University, and also the Prof of School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China |
For the second Lundbeck Science Award, there are seven applicants for clinical and only one for basic research field. After the scoring from the Award Committee, we are pleased to announce that Prof Tadafumi Kato wins the Clinical Science and Prof Zhong Chen wins the basic Science Award. Prof Tadafumi Kato is the Head of Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine. Tokyo, Japan. Prof Kato has published more than 300 Peer-reviewed original research articles and his major research interest is in the field of neuropsychopharmacology of bipolar disorder. Prof Chen is the President of Zhejiang Chinese Medical University, and also the Prof of School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. He has published more than 250 Peer-reviewed original research articles and his major research interest is in the field of neural circuit basis & molecular mechanisms of epileptogenesis and the development of antiepileptic drugs and the roles of histamine and histamine receptors in neurological disorder and the involvement of autophagy. Our President Tan Chay Hoon will invite them to give a special lecture during AsCNP Congress Singapore 2021.
Shih-Ku Lin,
Chair, Lundbeck Science Award Committee
| 2019 Awardee | |
| Toshi A. Furukawa (Japan) |
Professor and Chair of the Department of Health Promotion and Human Behavior, Professor of the Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan.
He has published more than 400 Peer-reviewed original research articles and his major research interest is in the field of mood disorders. |
|---|---|
| Brian Dean (Australia) |
Head, The Molecular Psychiatry Laboratory, The Florey Institute for Neuroscience and Mental Health, Parkville, Australia.
Deputy Director, The Victorian Brain Bank Network, The Florey Institute for Neuroscience and Mental Health, Parkville, Australia.
Principal Research Fellow, Centre for Mental Health, Swinburne University of Technology, Hawthorn, Australia.
Professorial Fellow, University of Melbourne, Parkville, Australia.
He has published more than 250 Peer-reviewed original research articles and his major research interest is in the field of molecular abnormalities underpinning the pathophysiology of psychiatric disorders and new drug target of for treatment. |